Inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by parabens: Mechanistic insights into cortisol metabolism disruption and structure-activity relationship and in silico docking

Parabens are widely used as antimicrobial preservatives in cosmetics, personal care products, and pharmaceuticals. However, their endocrine-disrupting potential, particularly their impact on 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), remains unclear. This study evaluated 9 parabens for their inhibitory potency against human placental and rat renal 11β-HSD2, mode of action, structure-activity relationship (SAR), molecular interactions (via in silico docking) and surface plasmon resonance (SPR) binding analysis, and effects on HSD11B2 expression and cortisol metabolism in human placental BeWo cells. Nonyl paraben was the most potent inhibitor in both species, with the lowest IC<sub>50</sub> (human: 15.24 μM, rat: 10.79 μM) and strongest binding affinity (KD: human 3.38 × 10<sup>-5</sup> M; ΔG: human: -6.43 kcal/mol, rat: -6.37 kcal/mol). Short-chain parabens (<C4) and paraben acid showed no inhibition at 100 μM, suggesting chain length-dependent activity. All active parabens exhibited mixed inhibition, binding both the free enzyme and the enzyme-substrate complex. These parabens also inhibited cortisol metabolism in intact BeWo cells at or below 100 μΜ and both heptyl and nonyl parabens downregulated HSD11B2 expression. Molecular docking revealed that nonyl paraben interacts with the NAD<sup>+</sup> cofactor site in humans and rats. SAR analysis identified lipophilicity and molecular weight as key determinants of inhibitory strength, with higher values correlating with greater potency. A 3D-QSAR pharmacophore model confirmed hydrophobic interactions as essential for inhibition. Species-specific differences in binding mechanisms highlight the need for caution when extrapolating animal data to humans. These results provide critical insights into the endocrine-disrupting effects of parabens, emphasizing their potential to interfere with cortisol homeostasis in a structure and species-dependent manner.

Authors

Institutions

Publication Details

Journal
Ecotoxicology and Environmental Safety
Published
2025-10-01
DOI
https://doi.org/10.1016/j.ecoenv.2025.119174
Citations
1
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by parabens: Mechanistic insights into cortisol metabolism disruption and structure-activity relationship and in silico docking

Huitao Li, Xishi Chen, Ren-shan Ge, Yunbing Tang et al.
1 citations
Ecotoxicology and Environmental Safety
Hormonal Regulation and Hypertension
1.29
article

Inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by parabens: Mechanistic insights into cortisol metabolism disruption and structure-activity relationship and in silico docking

Huitao Li, Xishi Chen, Ren-shan Ge, Yunbing Tang, Yingfen Ying, Jingyi Zheng, Chunnan Hu, Chentao Ding
article en
1 citations

Abstract

Parabens are widely used as antimicrobial preservatives in cosmetics, personal care products, and pharmaceuticals. However, their endocrine-disrupting potential, particularly their impact on 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), remains unclear. This study evaluated 9 parabens for their inhibitory potency against human placental and rat renal 11β-HSD2, mode of action, structure-activity relationship (SAR), molecular interactions (via in silico docking) and surface plasmon resonance (SPR) binding analysis, and effects on HSD11B2 expression and cortisol metabolism in human placental BeWo cells. Nonyl paraben was the most potent inhibitor in both species, with the lowest IC<sub>50</sub> (human: 15.24 μM, rat: 10.79 μM) and strongest binding affinity (KD: human 3.38 × 10<sup>-5</sup> M; ΔG: human: -6.43 kcal/mol, rat: -6.37 kcal/mol). Short-chain parabens (<C4) and paraben acid showed no inhibition at 100 μM, suggesting chain length-dependent activity. All active parabens exhibited mixed inhibition, binding both the free enzyme and the enzyme-substrate complex. These parabens also inhibited cortisol metabolism in intact BeWo cells at or below 100 μΜ and both heptyl and nonyl parabens downregulated HSD11B2 expression. Molecular docking revealed that nonyl paraben interacts with the NAD<sup>+</sup> cofactor site in humans and rats. SAR analysis identified lipophilicity and molecular weight as key determinants of inhibitory strength, with higher values correlating with greater potency. A 3D-QSAR pharmacophore model confirmed hydrophobic interactions as essential for inhibition. Species-specific differences in binding mechanisms highlight the need for caution when extrapolating animal data to humans. These results provide critical insights into the endocrine-disrupting effects of parabens, emphasizing their potential to interfere with cortisol homeostasis in a structure and species-dependent manner.

Ecotoxicology and Environmental SafetyVol. 305
Wenzhou Medical University (CN), Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Openalex Percentile: Top 15%
Hormonal Regulation and Hypertension
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.